Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-023603
Filing Date
2023-04-06
Accepted
2023-04-06 17:03:38
Documents
2
Period of Report
2023-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1537
2 POA DOCUMENT poa.txt EX-24 2835
  Complete submission text file 0001209191-23-023603.txt   5932
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Issuer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Jain Rita (Reporting) CIK: 0001707797 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37985 | Film No.: 23806998